Relationship Between Hemodynamic Change and Fluid Removed During Hemodialysis

April 2, 2019 updated by: National Taiwan University Hospital

Relationship Between Hemodynamic Change and Fluid Removed During Hemodialysis Measured by Non-invasive Monitor

Relationship between hemodynamic change and fluid removed during hemodialysis measured by non-invasive monitor

Study Overview

Detailed Description

By applying non-invasive hemodynamic monitors (ex. ClearSight, I-COM), the trends of mean arterial pressure (MAP), stroke volume (SV), cardiac index (CI) and calculated systemic vascular resistance (SVR) were collected along with volume removal by hemodialysis on ESRD patients. All data were compared and analyzed to detect the sequential body volume status as well as the autonomic responses during hemodialysis.

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan, 100
        • National Taiwan University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

end-stage renal disease patients who were under regular hemodialysis

Description

Inclusion criteria:

1. Patients who were schedured with regular hemodialysis for end-stage renal disease.

Exclusion criteria:

  1. Emergent hemodialysis
  2. Medical conditions with poor peripheral circulation such as Raynaud's disease or PAOD
  3. Skin defects or wounds over area to be applied for measurement (Wrist and fingers)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
With Clear Sight
record and observe the data including SVI, CI, SVR with clearSight during hemodialysis
MAP, HR, CO, SVI, from Non-invasive hemodynamic monitor

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
fluid removed along with hemodialysis
Time Frame: 4 hours
the fluid volume removed from hemodialysis (mL/hour),
4 hours
changes of mean arterial pressure along with hemodialysis
Time Frame: 4 hours
record of mean arterial pressure (mmHg) per 30 minutes
4 hours
changes of heart rate along with hemodialysis
Time Frame: 4 hours
record of heart rate (beats/ minute) per 30 minutes
4 hours
changes of stroke volume along with hemodialysis
Time Frame: 4 hours
record of stroke volume (SV, (mL/ beat)per 30 minutes
4 hours
changes of cardiac output along with hemodialysis
Time Frame: 4 hours
record of cardiac output ( liter/ minute)per 30 minutes
4 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: ST Chen, National Taiwan University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 6, 2017

Primary Completion (Actual)

November 23, 2018

Study Completion (Actual)

November 30, 2018

Study Registration Dates

First Submitted

March 11, 2019

First Submitted That Met QC Criteria

April 2, 2019

First Posted (Actual)

April 3, 2019

Study Record Updates

Last Update Posted (Actual)

April 3, 2019

Last Update Submitted That Met QC Criteria

April 2, 2019

Last Verified

April 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 201702064RIPB

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemodialysis Complication

Clinical Trials on Non-invasive hemodynamic monitor

3
Subscribe